Taken together, our study confirms that cDCBLD2 can regulate TOP2A expression through miR-345-5p competitively binding to the coding region of TOP2A mRNA, thus affecting both sorafenib resistance and the caspase-3-mediated apoptosis process in HCC cells (Fig. 7). The gene discussed is TOP2A; the disease is hepatocellular carcinoma.